Palo Alto Investors LP Bicycle Therapeutics PLC Transaction History
Palo Alto Investors LP
- $626 Million
- Q4 2024
A detailed history of Palo Alto Investors LP transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Palo Alto Investors LP holds 248,934 shares of BCYC stock, worth $2.9 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
248,934
Previous 59,582
317.8%
Holding current value
$2.9 Million
Previous $1.35 Million
157.96%
% of portfolio
0.56%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding BCYC
# of Institutions
104Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$127 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$53.1 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$40.3 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$30.4 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$25.6 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $346M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...